Private Equity, VC & Investor
Adelie vs Breega
Structured technology and market comparison · 2026
Direct Feature Comparison
Adelie · vs · BreegaMulti-stage technology investment firm based in Paris and London.
European and African early-stage venture capital fund manager.
Analyze all overlapping signals and tech stacks for Adelie and Breega
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Adelie and Breega?
Adelie and Breega occupy distinct tiers within the European investment ecosystem. Adelie functions as a multi-stage technology investment firm bridging Paris and London, targeting capital allocation across broader corporate lifecycles. Conversely, Breega operates as an international early-stage venture fund manager with dual focus across Europe and Africa, prioritizing founder selection and early equity appreciation.
How do the features of Adelie and Breega compare?
From an enterprise architecture and capital deployment perspective, Adelie offers multi-stage financial instruments suited for scalable growth phases. Breega specializes in early-stage venture backing, delivering foundational capital and operational scaleup support. Enterprise buyers and founders choose Adelie for multi-stage velocity or Breega for seed-level acceleration and transatlantic ecosystem access.
What are the top alternatives to Adelie and Breega?
When evaluating Adelie and Breega, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Adelie and Breega compare?
Adelie is headquartered in FR (founded in 2018) with <10 employees. Breega is based in FR (founded in 2013) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Adelie vs Breega
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Adelie
Recent Signals
No recent market signals documented for Adelie in the current tracking window.
Breega
Recent Signals
- ·EU-Startups (European Venture)Funding
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Adelie and Breega share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks